ENTITY

MorphoSys AG (MOR US)

5
Analysis
Health CareGermany
MorphoSys AG operates as a biopharmaceutical company. The Company discovers and develops differentiated therapies and medicines for the patients suffering from cancer, inflammations, and autoimmune diseases. MorphoSys serves customers in Germany.
more
27 Feb 2024 15:44

Quiddity Leaderboard SE600 Mar 24: 12 Changes Possible in the Next Few Days

LXI REIT's intra-review deletion and the replacement name could be confirmed over the next few days. Separately, I see 11 ADDs/DELs during the...

Share
21 Feb 2024 19:11

Quiddity Leaderboard DAX/MDAX Mar 24: M&A Candidates Morphosys and Vitesco Could Face Index Flows

I expect Vitesco Technologies Group (VTSC GR) to trigger the fast exit rule and get deleted from the MDAX index and MorphoSys AG (MOR GR) could get...

Share
bullishLawson Inc
11 Feb 2024 07:00

Last Week in Event SPACE: Mitsui Fudosan/Oriental Land, Giordano, JSR, Pasona, Lawson, L'Occitane

The weekend is here! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed...

Logo
583 Views
Share
bullishBefesa
16 Jan 2024 19:43

Quiddity Leaderboard DAX/MDAX Mar 24: Lufthansa, Zalando, Telefonica, Befesa

I expect Telefonica Deutschland to be deleted from the MDAX index in January 2024 once the Tender Offer results are confirmed. If this happens,...

Share
22 Jun 2023 05:02

Consolidation Likely, But Little Reason to Be Bearish; Buys Within Biotech, Latin American Banks

$SPX is 1% above 4300-4325 which we anticipated would cap upside for 2023. Our view since May 30 (ETF Pathfinder) is we cannot be bearish if SPX is...

Logo
321 Views
Share
x